SPPILawsuits•prnewswire•
Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline
Sentiment:Negative (-40)
Summary
SPPI Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Aug. 12, 2025 /PRNewswire/ -- On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by prnewswire